Patent · US Expired

Preparation of antiserum for quantitative determination of X and Y degradation products of fibrin and fibrinogen

US4147765A · kind A · utility

17Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 1976
Grant dateApr 3, 1979
Priority date
Expiry dateJul 16, 1996

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/83
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An antiserum for the quantitative determination of X and Y degradation products of fibrin and fibrinogen is produced by administering the purified degradation products to an experimental animal thereby to immunize said animal, drawing serum from said animal, contacting said serum with a plasma and separating the resultant precipitate, thereby to leave a supernatant liquid which constitutes said antiserum. The plasma may be a heparin, citrate, oxalate, ethylenediaminetetracetate or glutaraldehyde-treated plasma and as many as 12 or 15 precipitations may be made with the animal antiserum. The antiserum may be fractionated at any stage by adsorption on Sephadex modified dextran.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.